Research output per year
Research output per year
Personal profile
Research interests
My primary research interest is to develop and conduct phase I and II clinical trials with novel agents for patients with newly diagnosed or relapsed lung cancer. I am also interested in clinical trial methodology and medical education.
Clinical interests
Thoracic oncology, lung cancer
Fingerprint
Dive into the research topics where Maria Baggstrom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Racialized Economic Segregation and Disparities in Non-Small Cell Lung Cancer Care and Outcomes
Shrestha, P., Lian, M., Struthers, J., Nabi, O., Bekele, B. B., Kozower, B., Baggstrom, M. & Liu, Y., Mar 2025, In: CHEST Pulmonary. 3, 1, 100101.Research output: Contribution to journal › Article › peer-review
Open Access -
Prevalence of Women in Medicine Programs at University-Based Internal Medicine Residency Programs
Rho, S., Rust, A., Zhong, L., Lee, K., Spencer, A., Baggstrom, M. Q. & Bhayani, R. K., Feb 1 2024, In: Southern medical journal. 117, 2, p. 98-101 4 p.Research output: Contribution to journal › Article › peer-review
-
Racialized Economic Segregation and Treatment and Outcomes of Small Cell Lung Cancer
Bekele, B. B., Lian, M., Shrestha, P., Nabi, O., Kozower, B., Baggstrom, M. Q. & Liu, Y., Aug 1 2024, In: Cancer Epidemiology Biomarkers and Prevention. 33, 8, p. 1091-1097 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Investing in Women Trainees: Building a Women in Medicine Group at an Academic Institution
Zhong, L., Lee, K., Baggstrom, M. Q. & Bhayani, R. K., 2023, In: Journal of medical Internet research. 25, e47783.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Bagegni, N. A., Park, H., Kraft, K., O-Toole, M., Gao, F., Waqar, S. N., Ratner, L., Morgensztern, D., Devarakonda, S., Amin, M., Baggstrom, M. Q., Liang, C., Selvaggi, G. & Wang-Gillam, A., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 487-497 11 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations